Biochemical disease-free survival following 125I prostate implantation.


PURPOSE To assess the 5-year clinical and biochemical results of ultrasound-guided permanent 125I brachytherapy in early adenocarcinoma of the prostate. Biochemical disease-free survival (BDFS) is reported, using PSA follow-up and is compared to the surgical and radiation therapy literature. METHODS AND MATERIALS From December 1988 through December 1993… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.